Skip to content
lifestyle.thenyctimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lunai Bioworks Inc.
Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
September 16, 2026
Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint
September 4, 2026
Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit
August 27, 2026
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson’s Disease Data Readout Targeted for First Half of 2027
August 4, 2026
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
August 4, 2026
LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS
June 17, 2026
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson’s and Rare Epilepsy AI Discovery Collaboration
May 28, 2026
Federal Judge Orders Expedited Discovery to Identify ‘John Doe’ Defendants ‘Naked’ Short-Sellers of Lunai Common Stock
May 22, 2026
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT
May 20, 2026
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP
May 4, 2026
1
2
Next Page
→